Member: RADAR on Drug Benefits

We would love your feedback!

April 8, 2021

RADAR on Drug Benefits strives to cover business strategies and analysis for health plans, employers, PBMs and pharmaceutical companies. Please let us know how we’re doing — and what we can do better — by taking this brief reader survey. CLICK HERE for the survey

To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.

Uber-ScriptDrop Deal Stirs Up Already Active Rx Delivery Space

April 8, 2021

Uber, seeking to expand its prescription delivery business nationwide, has inked a deal with pharmacy home delivery start-up ScriptDrop that makes Uber the default delivery app for a network of grocery store and independent pharmacies that spans 37 states.

To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.

GoodRx Benefits Patients But May Profit From ‘Broken’ System

April 8, 2021

GoodRx Inc. has captured the attention of the pharmaceutical industry by putting pricing data on patients’ smartphones, often allowing them to choose between multiple prices for one drug at the pharmacy counter. While the startup — which went public last fall — unquestionably saves money for consumers, some experts say that it is a viable business only because of dysfunction in the broader drug channel.

To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.

Evernorth Drug Trend Report Shows Varied Pandemic Impacts

With Chart: Cigna: Pandemic Led to Fewer New Scripts, Better Adherence

April 8, 2021

In the 2020 Drug Trend Report recently released by Evernorth, the Cigna Corp. division added yet another chapter to the growing volume of data detailing the profound effects that the COVID-19 pandemic has had on health care.

To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.

Vaccines Improve Public Opinion Of Pharma, Despite Cost Worries

With Chart: Public Holds Favorable Views of Big Pharma, But Still Wants Drug Pricing Reforms

April 8, 2021

In recent years, the pharmaceutical industry has not been popular with the public: Problems like the rising cost of prescription drugs and the opioid epidemic combined to make the industry the least popular nationwide in a 2019 Gallup poll. According to a recent poll, the public now thinks better of the industry due to the rapid development of COVID-19 vaccines — but still wants drug prices to be reined in.

To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.